RxDoctor Payments Data

William Evans, MD

Interventional Pain Medicine · Valdese, NCNPI 1558318535

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Boston Scientific at 37.9% of the total. That places this record below the midpoint for interventional pain medicine clinicians in NC, where the typical reported total is $2,787.

$2,785in general payments, 2019–2025

Across 97 payments — averaging $28.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Nevro Corp.$583
  • Biotronik NRO, Inc.$424
  • Painteq LLC$179
  • Forte Bio-pharma LLC$162
  • Medtronic$106
  • plus $274 from 8 others

What the payments were for

  • Food & beverage$2,785100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,785 in reported general payments places this provider in the 45th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$100,039
Medicare patients
284
Services billed
1,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate40$26,492
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen766$26,361
OxycontinOxycodone Hcl25$18,805
NucyntaTapentadol Hcl12$18,176
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen480$13,861
Fentanyl98$8,268
Morphine Sulfate ErMorphine Sulfate227$7,372
Buprenorphine26$6,772
Gabapentin259$6,327
Oxycodone Hcl226$5,261
Lidocaine36$3,424
Pregabalin78$2,538
Naloxone Hcl37$2,468
Diclofenac Sodium35$1,863
Tramadol Hcl ErTramadol Hcl20$1,714

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Valdese

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →